Characterization of Chronic Renal Allograft Dysfunction at Single Cell Resolution
Characterization of Kidney Small Extracellular Vesicles Released During Normothermic Machine Perfusion
Characterization of Retransplantation Following Graft Failure Due to Bkvn
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
Characterizing Kidney Transplant Recipients with SARS-CoV-2: An Academic Single Center Experience
Characterizing the Early Impact of the Kidney Accelerated Placement Project on Hard-to-place Kidneys
CHBP Induces Stronger Immunosuppressive CD127+ M-MDSC via Erythropoietin Receptor
Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-Term Outcomes from a Multicenter Cohort
Clazakizumab (clz, Anti-il-6 Antibody) Treatment Affects Il-6/il-6r Signaling by Increasing Soluble Gp130 (sgp130) in Hla-sensitized Kidney Transplant Patients (hs Ktx Pts) Treated for Chronic Antibody-mediated Rejection (cabmr)
Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 139
- Next Page »